Covered recipient · General Payments record
THOMAS T CHEN
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$1,918.87
- Reported across 105 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $363.51 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $100.55 | 6 |
| PFIZER INC. | $100.22 | 4 |
| Amgen Inc. | $53.93 | 2 |
| Merck Sharp & Dohme Corporation | $49.16 | 2 |
| GlaxoSmithKline, LLC. | $41.26 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.39 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $25.29 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117525231 | CMS |
| Amgen Inc. | $28.64 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115497568 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.39 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118266771 | CMS |
| GlaxoSmithKline, LLC. | $18.35 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116181467 | CMS |
| GlaxoSmithKline, LLC. | $22.91 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116465984 | CMS |
| Lilly USA, LLC | $13.29 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135438266 | CMS |
| Lilly USA, LLC | $16.42 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135484755 | CMS |
| Lilly USA, LLC | $14.62 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135484757 | CMS |
| Lilly USA, LLC | $19.74 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135438268 | CMS |
| Lilly USA, LLC | $16.04 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135464416 | CMS |
| Lilly USA, LLC | $20.44 | 12/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135465498 | CMS |
| Merck Sharp & Dohme LLC | $23.33 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141715319 | CMS |
| Merck Sharp & Dohme LLC | $25.83 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141715321 | CMS |
| PFIZER INC. | $29.55 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130991356 | CMS |
| PFIZER INC. | $19.57 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131840311 | CMS |
| PFIZER INC. | $25.44 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132126361 | CMS |
| PFIZER INC. | $25.66 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131102999 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.